Jonen (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate)

The potassium, sodium, and calcium ions in Jonen diffuse into the extracellular fluid of the epidermis, re‑establishing osmotic equilibrium and supporting ion‑dependent cellular processes. This helps normalise cellular function and promotes tissue repair.

The amount of Jonen to apply is determined by the prescribing clinician based on the size of the affected area, the underlying condition, and the patient’s overall electrolyte status. No standard dosing regimen is provided publicly.

Safety data for Jonen in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks and decide whether use is appropriate for each individual patient.

To request Jonen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Jonen delivers a combination of potassium, sodium, and calcium ions in a single solution, whereas many alternative products contain only one or two electrolytes. This broader ionic profile can be advantageous for comprehensive electrolyte restoration, but the choice depends on the specific clinical scenario and physician preference.

Store Jonen at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Follow standard aseptic handling procedures when opening the vial for application.

Jonen is applied topically to clean, intact skin. The prescribed amount is spread evenly over the affected area using a sterile gauze or applicator. The solution should be allowed to dry before covering the site with dressings, unless otherwise directed by a clinician.

Serious risks include allergic contact dermatitis, systemic electrolyte overload (especially hyperkalemia or hypernatremia) when large surface areas are treated, and severe hypersensitivity reactions such as urticaria or angioedema. Patients should be monitored for these signs, particularly if they have renal impairment.

Jonen should be avoided in individuals with known hypersensitivity to any of its components, in patients with severe renal dysfunction where systemic electrolyte accumulation is a concern, and on open wounds or compromised skin unless specifically ordered by a healthcare professional.